PYLARIFY® PET/CT or PET/MRI in Men With Favorable Intermediate Risk (FIR) Prostate Cancer
PYLARIFY® PET/CT or PET/MRI in Men With Favorable Intermediate Risk (FIR) Prostate Cancer
Active, not recruiting · NCT06074510 · Registry updated 2025-09-11Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| PYLARIFY® PET/CT or PET/MRI in Men With Favorable Intermediate Risk (FIR) Prostate Cancer | Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder | Active, not recruiting | Phase 4 | 2025-09-11 | NCT06074510 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Lantheus Medical Imaging | 15 |
14 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| BAMF Health | Grand Rapids | United States | 15 |
| Cleveland Clinic | Cleveland | United States | 558 |
| Emory University | Atlanta | United States | 262 |
| Hoag Cancer Center | Irvine | United States | 1 |
| Huntsman Cancer Institute University of Utah | Salt Lake City | United States | 2 |
| Johns Hopkins University | Baltimore | United States | 60 |
| Karmanos Cancer Institute Wayne State University | Detroit | United States | 1 |
| Massachusetts General Hospital | Boston | United States | 1015 |
| Oregon Health & Science University | Portland | United States | 261 |
| Tower Urology | Los Angeles | United States | 9 |
| University of Alabama at Birmingham | Birmingham | United States | 35 |
| University of California San Francisco | San Francisco | United States | 80 |
| University of Iowa Health Care | Iowa City | United States | 47 |
| Washington University School of Medicine | St Louis | United States | 895 |